| Product Name | MF | CAS | Details |
|---|
| Cyclandelate (200 mg) (DISCONTINUED) | C17H24O3 | 456-59-7 | Details |
| Cyclic Olefin Copolymer (3 strips, 2'' x 2'' x 1 mm each) | C9H14 | 26007-43-2 | Details |
| Cyclizine Hydrochloride (200 mg) | C18H23ClN2 | 303-25-3 | Details |
| Cyclohexanecarboxylic Acid (500 mg) (PLANNED TO BE DISCONTINUED) | C7H12O2 | 98-89-5 | Details |
| Cyclohexylmethanol (1 mL/ampule; 2 ampules) | C7H14O | 100-49-2 | Details |
| Cyclopropyldiaminopurine (25 mg) (N6-cyclopropyl-9H-purine-2,6-diamine) | C8H10N6 | 120503-69-7 | Details |
| Cyclothiazide (200 mg) (AS) (DISCONTINUED) | C14H16ClN3O4S2 | 2259-96-3 | Details |
| Cyproheptadine Hydrochloride (500 mg) | C21H24ClNO | 41354-29-4 | Details |
| Cyproheptadine Related Compound C (25 mg) (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol) | C21H23NO | 3967-32-6 | Details |
| D-Salicin (150 mg) | C13H18O7 | 138-52-3 | Details |
| D-Valacyclovir (25 mg) (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester) | C13H20N6O4 | 142963-60-8 | Details |
| Cyclopentolate Hydrochloride (300 mg) | C17H26ClNO3 | 5870-29-1 | Details |
| Cyclopentylpropanoic Acid (25 mg) (3-Cyclopentylpropanoic acid) | C8H14O2 | 140-77-2 | Details |
| Dalfampridine Related Compound B (50 mg) (3,5-Dibromopyridin-4-amine) | C5H4Br2N2 | 84539-34-4 | Details |
| Dalfampridine Related Compound C (25 mg) (1,3-Di(pyridin-4-yl)urea) | C11H10N4O | 39642-87-0 | Details |
| Low Molecular Weight Heparin for Boron Analysis (300 mg) | (C12H16NS2Na3)20 | 9041-08-1 | Details |
| D-chiro-Inositol (150 mg) | C6H12O6 | 643-12-9 | Details |
| Dacarbazine (125 mg) | C6H10N6O | 4342-03-4 | Details |
| Dacarbazine Related Compound A (50 mg) (5-aminoimidazole-4-carboxamide hydrochloride) | C4H7ClN4O | 72-40-2 | Details |
| Daidzein (25 mg) | C15H10O4 | 486-66-8 | Details |
| Dantrolene Sodium (100 mg) | C14H13N4NaO6 | 24868-20-0 | Details |
| Dapsone (200 mg) | C12H12N2O2S | 80-08-0 | Details |
| Darifenacin Related Compound G (25 mg) (5-(2-Bromoethyl)-2,3-dihydrobenzofuran) | C10H11BrO | 127264-14-6 | Details |
| Darunavir Ethanolate (100 mg) | C29H43N3O8S | 635728-49-3 | Details |
| Daunorubicin Hydrochloride (200 mg) | C27H29NO10.ClH | 23541-50-6 | Details |
| Deacetylnorgestimate (25 mg) ((E)- and (Z)-17-deacetyl norgestimate mixture) (PLANNED TO BE DISCONTINUED) | C21H29NO2 | 53016-31-2 | Details |
| Decoquinate (200 mg) | C24H35NO5 | 18507-89-6 | Details |
| Defatted Powdered Soy (2.5 g) | 68513-95-1 | Details |
| Deferasirox (200 mg) | C21H15N3O4 | 201530-41-8 | Details |
| Deferasirox Related Compound F (25 mg) (4-Hydrazinylbenzoic acid) | C7H8N2O2 | 619-67-0 | Details |
| Deflazacort (100 mg) | C25H31NO6 | 14484-47-0 | Details |
| Dehydroacetic Acid (200 mg) | C8H8O4 | 520-45-6 | Details |
| Dehydrocarteolol Hydrochloride (100 mg) (5-[3-(tert-Butylamino)-2-hydroxypropoxy]quinolin-2(1H)-one hydrochloride) | C16H23ClN2O3 | 53371-79-2 | Details |
| Desvenlafaxine Succinate (200 mg) (1-[2-(Dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol hydrogen butanedioate monohydrate) | C20H31NO6 | 386750-22-7 | Details |
| Desvenlafaxine Fumarate (200 mg) (1-[2-(Dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol trans-butenedioate monohydrate) | C20H29NO6 | 313471-75-9 | Details |
| Desvenlafaxine Benzyl Ether | C23H31NO2 | 93413-61-7 | Details |
| Despropyl Macitentan (COLD SHIPMENT REQUIRED) | C16H14Br2N6O4S | 1103522-45-7 | Details |
| Desoxycorticosterone Pivalate (125 mg) | C26H38O4 | 808-48-0 | Details |
| Desoxycorticosterone Acetate (200 mg) | C23H32O4 | 56-47-3 | Details |
| Desoximetasone Related Compound A (25 mg) (9-Fluoro-11Beta,21-dihydroxy-16Alpha-methylpregna-4-ene-3,20-dione) | C22H31FO4 | 432-54-2 | Details |
| Desogestrel Related Compound D (25 mg) (13-Ethyl-11-methylenegon-4-en-17-one) | C20H28O | 54024-21-4 | Details |
| Etonogestrel (100 mg) | C22H28O2 | 54048-10-1 | Details |
| Desogestrel Related Compound B (25 mg) (13-Ethyl-3-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol) | C22H30O2 | 869627-85-0 | Details |
| Desogestrel Related Compound A (15 mg) (13-Ethyl-11-methylene-18,19-dinor-5alpha,17alpha-pregn-3-en-20-yn-17-ol) | C22H30O | 201360-82-9 | Details |
| Desogestrel (100 mg) | C22H30O | 54024-22-5 | Details |
| Deslanoside (200 mg) | C47H74O19 | 17598-65-1 | Details |
| Desipramine Hydrochloride (125 mg) | C18H23ClN2 | 58-28-6 | Details |
| Desdiethylamino Sunitinib | C18H18FN3O2 | 1467015-10-6 | Details |
| Desbenzyl Donepezil Hydrochloride (20 mg) | C17H24ClNO3 | 120013-39-0 | Details |
| Denatonium Benzoate (200 mg) | C28H34N2O3 | 3734-33-6 | Details |
| Demeclocycline Hydrochloride (200 mg) (COLD SHIPMENT REQUIRED) | C21H22Cl2N2O8 | 64-73-3 | Details |
| Demecarium Bromide (100 mg) | C32H52Br2N4O4 | 56-94-0 | Details |
| Delta-Damascone (3 x 0.5 mL) (DISCONTINUED) | C13H20O | 57378-68-4 | Details |
| Delta-9-Tetrahydrocannabinol 1 mL (1 mg/mL) | Details |
| Diaveridine (25 mg) (5-(3,4-Dimethoxybenzyl)pyrimidine-2,4-diamine) | C13H16N4O2 | 5355-16-8 | Details |
| Deutero N-Nitrosodibutylamine (NDBA-d18 ) Solution (1 mL (1 mg/mL) (N,N-Bis(butyl-d9)nitrous amide)) | C8D18N2O | 1219798-82-9 | Details |
| Deutero N-Nitrosodiethylamine (NDEA-d10) Solution (1 mL (1 mg/mL) (N,N-Bis(ethyl-d5)nitrous amide)) | (C2D5)2NNO | 1219794-54-3 | Details |
| Dexamethasone Ethyl Ester (25 mg) (COLD SHIPMENT REQUIRED) (Ethyl 11Beta,17alpha-dihydroxy-9-fluoro-16alpha-methylandrostane-1,4-diene-3-one-17-ylcarboxylate) | C23H31FO5 | 2991360-83-7 | Details |
| Dexbrompheniramine Maleate (200 mg) | C20H23BrN2O4 | 2391-03-9 | Details |
| Dexchlorpheniramine Maleate (300 mg) | C20H23ClN2O4 | 2438-32-6 | Details |
| Dextrose (500 mg) | C6H12O6 | 50-99-7 | Details |
| Diacetylfluorescein (200 mg) | C24H16O7 | 596-09-8 | Details |
| Diatrizoic Acid (100 mg) | C11H11I3N2O5 | 50978-11-5 | Details |
| Diatrizoic Acid Related Compound A (50 mg) (5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid) | C9H7I3N2O3 | 1713-07-1 | Details |
| Dinaphthyl Thiocarbonate (25 mg) (O,O-dinaphthalen-2-yl carbonothioate) | C21H14O2S | 127084-74-6 | Details |
| Dinoprost Tromethamine (50 mg) | C24H45NO8 | 38562-01-5 | Details |
| Dinoprostone (125 mg) (COLD SHIPMENT REQUIRED) | C20H32O5 | 363-24-6 | Details |
| Dinoprostone Related Compound C (20 mg) ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid) | C20H32O5 | 36150-00-2 | Details |
| Dibutyl Sebacate (1 mL) | C18H34O4 | 109-43-3 | Details |
| Dichlorphenamide (200 mg) | C6H6Cl2N2O4S2 | 120-97-8 | Details |
| Diclazuril (200 mg) | C17H9Cl3N4O2 | 101831-37-2 | Details |
| Diclofenac Keto Analog (25 mg) | C14H9Cl2NO3 | 66156-75-0 | Details |
| Dicloxacillin Related Compound D (15 mg) (3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid) | C11H7Cl2NO3 | 3919-76-4 | Details |
| Dicyclomine Hydrochloride (125 mg) | C19H36ClNO2 | 67-92-5 | Details |
| Didanosine System Suitability Mixture (10 mg) | C10H12N4O3 | 69655-05-6 | Details |
| Didanosine Related Compound B (25 mg) (2',3'-dideoxyadenosine) | C10H13N5O2 | 4097-22-7 | Details |
| Diethyl Sebacate (1 mL) | C14H26O4 | 110-40-7 | Details |
| Diethylene Glycol Monoethyl Ether (4 x 0.25 mL/ampule) | C6H14O3 | 111-90-0 | Details |
| Diethyltoluamide (3 g) | C12H17NO | 134-62-3 | Details |
| Diethyltoluamide Related Compound A (25 mg) (N,N-Diethyl-4-toluamide) | C12H17NO | 2728-05-4 | Details |
| Digitalis (3 g) | 8031-42-3 | Details |
| Dihydroartemisinin (200 mg) ((3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-Trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-ol) | C15H24O5 | 131175-87-6 | Details |
| Dihydroergotamine Mesylate (500 mg) | C33H37N5O5.CH4O3S | 6190-39-2 | Details |
| Dihydrostreptomycin Sulfate (200 mg) | C21H43N7O16S | 5490-27-7 | Details |
| Diloxanide Furoate (200 mg) | C14H11Cl2NO4 | 3736-81-0 | Details |
| Dimethylamine Solution (6 x 3 mL) (International Restricted Sales Item) | Details |
| Dimethylethylamine Hydrochloride (25 mg) (N,N-dimethylethanamine, hydrochloride) | C4H12ClN | 58114-25-3 | Details |
| Diosmin (300 mg) | C28H32O15 | 520-27-4 | Details |
| Dioxybenzone (150 mg) | C14H12O4 | 131-53-3 | Details |
| Diphenhydramine N-Oxide (25 mg) (2-(benzhydryloxy)-N,N-dimethylethan-1-amine oxide hydrochloride) | C17H21NO2.ClH | 13168-00-8 | Details |
| Diphenhydramine Related Compound B (20 mg) (3-(benzhydryloxy)propane-1,2-diol) | C16H18O3 | 19574-66-4 | Details |
| Disodium Inosinate (500 mg) | C10H16N4NaO9P | 352195-40-5 | Details |
| Disopyramide Phosphate (200 mg) | C21H32N3O5P | 22059-60-5 | Details |
| Desacetyl Diltiazem Hydrochloride (50 mg) | C20H25ClN2O3S | 23515-45-9 | Details |
| Didymin (30 mg) ((RS)-5-Hydroxy-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) | C28H34O14 | 2418540-64-2 | Details |
| Diacetylated Monoglycerides (200 mg) | 8029-92-3 | Details |
| Dextrates Monohydrate (550 mg) | 39404-33-6 | Details |
| Dacarbazine Related Compound B (50 mg) (2-Azahypoxanthine monohydrate) | C4H5N5O2 | 7151-03-3 | Details |
| Dicyclomine Related Compound A (40 mg) ([1,1'-Bi(cyclohexane)]-1-carboxylic acid) | C13H22O2 | 60263-54-9 | Details |
| Product Total： Product Page： | ||||
| 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 | ||||